Post-marketing evaluation of the short term safety of COMVAX.
Davis RL, Black S, Shinefield H, Mahoney L, Zavitkovsky A, Lewis E, Nikas A, Guess H, Coplan P.
Davis RL, et al. Among authors: shinefield h.
Vaccine. 2004 Jan 2;22(3-4):536-43. doi: 10.1016/j.vaccine.2003.06.001.
Vaccine. 2004.
PMID: 14670337